The authorization covers therapy of innovative or recurring cervical cancer cells and is the only accepted antibody treatment in the EU, according to Genmab
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/genmab-gets-european-approval-for-cervical-cancer-treatment/